Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets
Shares of Concord Biotech rose over 6% to their day’s high of Rs 1,350 on the BSE on Wednesday after ...
Sunday, September 6, 2026
Tag: Tofacitinib
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.